Inventor
WEINSTABL HARALD
AT11 patents
Patents
11 patentsUS10144739B2Dec 4, 2018
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT9 citations82
US10246467B2Apr 2, 2019
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
BOEHRINGER INGELHEIM INT9 citations81
US10138251B2Nov 27, 2018
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT6 citations71
US10919913B2Feb 16, 2021
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
BOEHRINGER INGELHEIM INT2 citations70
US10576064B2Mar 3, 2020
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT1 citations61
USRE50594ESep 23, 2025
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT0 citations60
US12312363B2May 27, 2025
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
BOEHRINGER INGELHEIM INT0 citations60
US10882866B1Jan 5, 2021
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT0 citations60
US11304929B2Apr 19, 2022
Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors
BOEHRINGER INGELHEIM INT0 citations50
US10717742B2Jul 21, 2020
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
BOEHRINGER INGELHEIM INT0 citations49
US12281099B2Apr 22, 2025
Isoindolinone substituted indoles and derivatives as RAS inhibitors
BOEHRINGER INGELHEIM INT0 citations47